Skip to main content
. 2022 Sep 8;25(3):486–497. doi: 10.1093/ntr/ntac210

Figure 2. (.

Figure 2. (

a) Averted smoking- and vaping-attributable deaths (SVADs) and life years lost (LYLs) with nicotine vaping product (NVP) relative risks [2.5%−50.0%] by gender and both genders, ages 18−99, 2021−2080. (b) Averted LYLs with NVP Relative Risks [2.5%−50.0%] by gender and both genders, ages 18−99, 2021−2080.